MDT up .30 to $46.42
Medtronic (MDT) announces FDA approval to begin clinical trial of first pacemaker system designed for safe use in MRI machines.
Monday, January 28, 2008
Subscribe to:
Post Comments (Atom)
Timely News, Ideas and Strategies for Active Investors
No comments:
Post a Comment